amitriptyline has been researched along with dronabinol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kaneto, H; Koida, M; Miyagawa, H; Tsuchie, F | 1 |
| De Vry, J; Jentzsch, KR | 1 |
| Faugno, D; Gaensslen, RE; Greene, P; Haner, B; Juhascik, MP; Ledray, L; Lindner, A; Negrusz, A | 1 |
| Fitzcharles, MA; Joseph, L; Shir, Y; Ware, MA | 1 |
| Fitzcharles, MA; Häuser, W; Klose, P; Phillips, T; Walitt, B | 1 |
2 review(s) available for amitriptyline and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cannabinoids for fibromyalgia.
Topics: Adult; Aged; Amitriptyline; Analgesics, Non-Narcotic; Cannabinoids; Dronabinol; Fibromyalgia; Health Status; Humans; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic | 2016 |
1 trial(s) available for amitriptyline and dronabinol
| Article | Year |
|---|---|
The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.
Topics: Adult; Aged; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain Measurement; Patient Satisfaction; Sleep; Sleep Initiation and Maintenance Disorders | 2010 |
8 other study(ies) available for amitriptyline and dronabinol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Screening procedure for barbital type physical dependence liability of psychotropic drugs in mice].
Topics: Amitriptyline; Animals; Barbiturates; Behavior, Animal; Benzazepines; Benzodiazepinones; Body Weight; Carboxylic Acids; Chlordiazepoxide; Chlorpromazine; Diazepam; Doxepin; Dronabinol; Humans; Imines; Isoquinolines; Male; Mice; Morphine; Nitrazepam; Oxazoles; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranquilizing Agents | 1973 |
Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat.
Topics: Alkanesulfonates; Amines; Amitriptyline; Animals; Baclofen; Behavior, Animal; Benzoxazines; Carbamazepine; Cyclohexanecarboxylic Acids; Cyclohexanols; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Gabapentin; gamma-Aminobutyric Acid; Indans; Male; Molecular Structure; Morphine; Morpholines; Naphthalenes; Nitriles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sulfonic Acids | 2004 |
An estimate of the proportion of drug-facilitation of sexual assault in four U.S. localities.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Amitriptyline; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors; Doxylamine; Dronabinol; Ethanol; Female; Flunitrazepam; Forensic Toxicology; Hair; Histamine H1 Antagonists; Humans; Hydromorphone; Male; Narcotics; Nortriptyline; Oxazepam; Oxycodone; Psychotropic Drugs; Sex Offenses; Substance Abuse Detection; United States | 2007 |